Ki-ras Gene Mutations Are Invariably Present in Low-grade Mucinous Tumors of the Vermiform Appendix
Overview
Affiliations
Objective: Low-grade mucinous tumors of the appendix appear to have a simple histological structure. Paradoxically, reports have suggested a greater frequency of Ki-ras gene mutation in these lesions than in more complex lesions such as benign colonic adenomas and carcinomas. We assessed several molecular genetic changes, including Ki-ras gene mutations, in a large series of low-grade mucinous tumors of the appendix.
Material And Methods: We retrospectively ascertained low-grade mucinous tumors of the appendix from computerized pathology records. Extracted DNA was analyzed for APC and DCC gene loss of heterozygosity, microsatellite instability and for the presence of Ki-ras gene mutation using standard molecular techniques. Controls consisted of normal appendices, other appendiceal neoplasms, and ovarian mucinous cystadenomas.
Results: A total of 31 low-grade appendiceal mucinous tumors were identified. All were microsatellite stable and none demonstrated loss of heterozygosity for the APC or DCC genes. By contrast, all 31 lesions contained a Ki-ras gene mutation.
Conclusions: The presence of a Ki-ras gene mutation in all lesions, with no other molecular changes identified, strongly suggests a possible etiological role of the Ki-ras mutation in the development of this particular lesion of the appendix. Based on other work regarding intestinal bacteria, we hypothesize a relationship between chronic inflammation of the appendix from bacterial overgrowth and Ki-ras gene mutation.
Landscape of Genetic Mutations in Appendiceal Cancers.
Constantin M, Matanie C, Petrescu L, Bolocan A, Andronic O, Bleotu C Cancers (Basel). 2023; 15(14).
PMID: 37509254 PMC: 10377024. DOI: 10.3390/cancers15143591.
Murage N, Ahmed N, Underwood T, Walters Z, Breininger S Cancer Metastasis Rev. 2023; 42(1):335-359.
PMID: 36723696 PMC: 10014681. DOI: 10.1007/s10555-023-10088-0.
Peptide vaccine targeting mutated : a potential novel treatment for pseudomyxoma peritonei.
Flatmark K, Torgunrud A, Fleten K, Davidson B, Juul H, Mensali N J Immunother Cancer. 2021; 9(10).
PMID: 34711663 PMC: 8557294. DOI: 10.1136/jitc-2021-003109.
Lu Y, Qi C, Xu H, Jin M J Cancer Res Clin Oncol. 2021; 148(7):1761-1769.
PMID: 34368907 DOI: 10.1007/s00432-021-03757-6.
Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms.
Kang D, Kim B, Kim J, Kim J, Chang H, Chang M J Pathol Transl Med. 2021; 55(4):247-264.
PMID: 34233112 PMC: 8353140. DOI: 10.4132/jptm.2021.05.28.